SEC Contract Filing

Filing Date: 2020-09-04

Document Content:
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>ea126481ex10-3_cmlife.htm
<DESCRIPTION>REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 1, 2020, BY AND AMONG THE COMPANY, CMLS HOLDINGS LLC AND THE OTHER HOLDERS PARTY THERETO
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTION
VERSION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION
RIGHTS AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
REGISTRATION RIGHTS AGREEMENT (this &ldquo;<B><I>Agreement</I></B>&rdquo;)<I>,</I> dated as of September&nbsp;1,&nbsp;2020, is
made and entered into by and among CM Life Sciences, Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;)<I>,
</I>CMLS Holdings LLC, a Delaware limited liability company (the &ldquo;<B><I>Sponsor</I></B>&rdquo;) and the undersigned parties
listed on the signature page hereto under &ldquo;Holders&rdquo; (each such party, including the Sponsor and any person or entity
who hereafter becomes a party to this Agreement pursuant to <U>Section 5.2</U> of this Agreement, a &ldquo;<B><I>Holder</I></B>&rdquo;
and collectively, the &ldquo;<B><I>Holders</I></B>&rdquo;)<I>.</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company has 11,068,750 shares of Class B common stock, par value $0.0001 per share (the &ldquo;<B><I>Founder Shares</I></B>&rdquo;)<I>,
</I>issued and outstanding, up to 1,443,750 of which will be forfeited by the Sponsor to the Company for no consideration depending
on the extent to which the underwriters of the Company&rsquo;s initial public offering exercise their over-allotment option;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Founder Shares are convertible into shares of the Company&rsquo;s Class A common stock, par value $0.0001 per share (&ldquo;<B><I>Common
Stock</I></B>&rdquo;)<I>,</I> at the time of the initial Business Combination (as defined below) on the terms and conditions provided
in the Company&rsquo;s amended and restated certificate of incorporation, as may be amended from time to time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on September 1, 2020, the Company and the Sponsor entered into that certain Private Placement Warrants Purchase Agreement (the
&ldquo;<B><I>Private Placement Warrants Purchase Agreement</I></B>&rdquo;)<I>,</I> pursuant to which the Sponsor and certain of
the Company&rsquo;s directors agreed to purchase 6,466,667 warrants (or up to 7,236,667 warrants to the extent that the over-allotment
option in connection with the Company&rsquo;s initial public offering is exercised in full) in aggregate (the &ldquo;<B><I>Private
Placement Warrants</I></B>&rdquo;) in a private placement transaction occurring simultaneously with the closing of the Company&rsquo;s
initial public offering;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
in order to finance the Company&rsquo;s transaction costs in connection with its search for and consummation of an initial Business
Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company&rsquo;s officers and directors may loan to the
Company funds as